Safety, pharmacokinetics, and pharmacodynamics of S-(−)-pantoprazole sodium injections after single and multiple intravenous doses in healthy Chinese subjects Hui-Wen JiaoLu-Ning SunYong-Qing Wang Clinical Trial 22 November 2017 Pages: 257 - 265
An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis Malin S. E. SkagerlindBernd G. Stegmayr Clinical Trial Open access 02 December 2017 Pages: 267 - 274
No major role of norepinephrine transporter gene variations in the cardiostimulant effects of MDMA Patrick VizeliHenriette E. Meyer zu SchwabedissenMatthias E. Liechti Pharmacogenetics Open access 02 December 2017 Pages: 275 - 283
Pharmacokinetics of CYP2C9, CYP2C19, and CYP2D6 substrates in healthy Chinese and European subjects Sijie LuR. A. NandA. S. Gross Pharmacokinetics and Disposition 27 November 2017 Pages: 285 - 296
Claiming desmopressin therapeutic equivalence in children requires pediatric data: a population PKPD analysis Robin MicheletLien DosscheOn behalf of the SAFE-PEDRUG consortium Pharmacokinetics and Disposition 03 December 2017 Pages: 297 - 305
Longitudinal patterns of potentially inappropriate prescribing in early old-aged people Christina Raae HansenStephen ByrnePatricia M. Kearney Pharmacoepidemiology and Prescription 25 November 2017 Pages: 307 - 313
Effectiveness of biosimilar filgrastim vs. original granulocyte colony-stimulating factors in febrile neutropenia prevention in breast cancer patients Isabel PuértolasAlberto Frutos Pérez-SurioMaría del Tránsito Salvador Pharmacoepidemiology and Prescription 19 November 2017 Pages: 315 - 321
Prescribing of NOACs has outnumbered warfarin: exploring how physicians choose anticoagulant treatments Anne Katrine EekErik ØieAnne Gerd Granas Pharmacoepidemiology and Prescription 17 November 2017 Pages: 323 - 330
Inter-rater reliability of STOPPFrail [Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy] criteria amongst 12 physicians Amanda Hanora LavanPaul GallagherDenis O’Mahony Pharmacoepidemiology and Prescription 20 November 2017 Pages: 331 - 338
Changes in prescription patterns in older hospitalized patients: the impact of FORTA on disease-related over- and under-treatments Farhad PazanHeinrich BurkhardtMartin Wehling Pharmacoepidemiology and Prescription 02 December 2017 Pages: 339 - 347
Baclofen in gamma-hydroxybutyrate withdrawal: patterns of use and online availability Christopher N. FloydDavid M. WoodPaul I. Dargan Pharmacoepidemiology and Prescription Open access 03 December 2017 Pages: 349 - 356
Measuring medication adherence in older community-dwelling patients with multimorbidity San KimKathleen BennettCaitriona Cahir Pharmacoepidemiology and Prescription 03 December 2017 Pages: 357 - 364
Development and pilot testing of PHARAO—a decision support system for pharmacological risk assessment in the elderly Ylva BöttigerKari LaineMarine L. Andersson Pharmacoepidemiology and Prescription Open access 02 December 2017 Pages: 365 - 371
Benefits, benefits, once more benefits... with no risk? Stop overlooking the harms of medicines Silvio GarattiniVittorio Bertele’ Point of View 27 November 2017 Pages: 373 - 375
Warfarin resistance from primidone in patient with essential tremor Joseph P. RindoneChadwick K. Mellen Letter to the Editor 23 November 2017 Pages: 377 - 378
A population-level study examining discontinuation of statins in older people with dementia Sujita W. NarayanSarah N. HilmerPrasad S. Nishtala Letter to the Editor 01 December 2017 Pages: 379 - 381